- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Blue chip stocks
Belgian Pharmaceuticals & Biotech Blue chip stocks
Results
2
0 new
2 companies
UCB
Market Cap: €31.0b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€162.95
7D
4.5%
1Y
35.9%
argenx
Market Cap: €34.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€566.60
7D
2.5%
1Y
54.6%